Literature DB >> 12926070

Immunocytochemical expression of Ki67 and laminin in Hurthle cell adenomas and carcinomas.

T Pisani1, F Pantellini, M Centanni, A Vecchione, M R Giovagnoli.   

Abstract

BACKGROUND: Hurthle cell neoplasms may occur as a benign adenoma or carcinoma; the latter displays comparatively aggressive clinical behaviour. Fine-needle aspiration cytology (FNAC) represents a reliable tool for screening Hurthle cell lesions before surgery. Nevertheless, the cytological interpretation of these lesions is not always unequivocal. We analyzed cell growth and cellular adhesiveness by means of two different antibodies, Mib1 (Ki67) and laminin. AIM: The aim of the study was to analyze Ki67 and laminin immunocytochemical expression on FNAC to evaluate their usefulness in the preoperative differential diagnosis of Hurthle cell neoplasms.
RESULTS: A higher expression of Ki67 has been recorded in malignant lesions as compared to benign ones (8% to 20% vs 1% to 5% nuclear staining, respectively; p < 0.001). An increased reactivity of anti-laminin antibody was recorded in the cytoplasm of cells from all malignant lesions. In Hurthle cell adenomas this adhesion molecule showed an intensity ranging from low to moderate. Moreover, a few benign lesions showing a moderate proliferative activity were associated with evident laminin expression.
CONCLUSION: These findings support the hypothesis that benign Hurthle cell lesions with a high cellular proliferation associated with an increased laminin expression could define a subset of lesions prone to malignant transformation. Conversely, since all cases with low expression of both laminin and Ki67 always correspond to adenomas, we suggest that the different expression of these two antibodies on FNAC can provide a further tool for the preoperative identification of lesions at low risk of malignancy, thus avoiding unnecessary surgery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12926070

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Thyroid Hürthle cell tumors: research of potential markers of malignancy.

Authors:  G Donatini; A Beaulieu; M Castagnet; J-L Kraimps; P Levillain; G Fromont
Journal:  J Endocrinol Invest       Date:  2015-07-19       Impact factor: 4.256

Review 2.  Do benign thyroid nodules have malignant potential? An evidence-based review.

Authors:  Nimmi Arora; Theresa Scognamiglio; Baixin Zhu; Thomas J Fahey
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

3.  Association of thyroid diseases with primary extra-thyroidal malignancies in women: results of a cross-sectional study of 6,386 patients.

Authors:  Natalie Prinzi; Salvatore Sorrenti; Enke Baldini; Corrado De Vito; Chiara Tuccilli; Antonio Catania; Carmela Coccaro; Marta Bianchini; Angela Nesca; Giorgio Grani; Renzo Mocini; Enrico De Antoni; Massimino D'Armiento; Salvatore Ulisse
Journal:  PLoS One       Date:  2015-03-31       Impact factor: 3.240

4.  High Ki-67 index in fine needle aspiration cytology of follicular thyroid tumors is associated with increased risk of carcinoma.

Authors:  Ninni Mu; C Christofer Juhlin; Edneia Tani; Anastasios Sofiadis; Eva Reihnér; Jan Zedenius; Catharina Larsson; Inga-Lena Nilsson
Journal:  Endocrine       Date:  2018-05-23       Impact factor: 3.633

5.  The value of thyroperoxidase as a prognostic factor for differentiated thyroid cancer -- a long-term follow-up study.

Authors:  Yurena Caballero; Eudaldo M López-Tomassetti; Julián Favre; José R Santana; Juan J Cabrera; Juan R Hernández
Journal:  Thyroid Res       Date:  2015-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.